Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1020

    1.

    Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.

    Mbugi EV, Mutayoba BM, Malisa AL, Balthazary ST, Nyambo TB, Mshinda H.

    Malar J. 2006 Oct 31;5:94.

    PMID:
    17076899
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.

    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.

    Acta Trop. 2005 Sep;95(3):183-93.

    PMID:
    16023986
    [PubMed - indexed for MEDLINE]
    3.

    High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.

    Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T.

    Acta Trop. 2003 Mar;85(3):363-73.

    PMID:
    12659974
    [PubMed - indexed for MEDLINE]
    4.

    Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.

    Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM.

    Am J Trop Med Hyg. 2003 Dec;69(6):601-6.

    PMID:
    14740875
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.

    Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.

    Am J Trop Med Hyg. 2004 Dec;71(6):696-702.

    PMID:
    15642957
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.

    Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH.

    Am J Trop Med Hyg. 2006 Feb;74(2):198-204.

    PMID:
    16474070
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.

    Schönfeld M, Barreto Miranda I, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Löscher T.

    Malar J. 2007 Jan 15;6:2.

    PMID:
    17224049
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.

    A-Elbasit IE, Alifrangis M, Khalil IF, Bygbjerg IC, Masuadi EM, Elbashir MI, Giha HA.

    Malar J. 2007 Aug 8;6:108.

    PMID:
    17686173
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    [Sulfadoxine-pyrimethamine resistance in Maputo, Mozambique: presence of mutations in the dhfr and dhps genes of Plasmodium falciparum].

    Fernandes NE, Cravo P, do Rosário VE.

    Rev Soc Bras Med Trop. 2007 Jul-Aug;40(4):447-50. Portuguese.

    PMID:
    17876469
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.

    Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.

    Malar J. 2008 Jul 1;7:115.

    PMID:
    18590577
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.

    Omar SA, Mens PF, Schoone GJ, Yusuf A, Mwangi J, Kaniaru S, Omer GA, Schallig HD.

    Exp Parasitol. 2005 May;110(1):73-9.

    PMID:
    15804381
    [PubMed - indexed for MEDLINE]
    12.

    Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes.

    Jelinek T, Kilian AH, Kabagambe G, von Sonnenburg F.

    Am J Trop Med Hyg. 1999 Sep;61(3):463-6.

    PMID:
    10497991
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.

    Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK.

    J Infect Dis. 1997 Dec;176(6):1590-6.

    PMID:
    9395372
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania.

    Eberl KJ, Jelinek T, Aida AO, Peyerl-Hoffmann G, Heuschkel C, el Valy AO, Christophel EM.

    Trop Med Int Health. 2001 Oct;6(10):756-60.

    PMID:
    11679122
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.

    Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U.

    Infect Genet Evol. 2004 Dec;4(4):321-7.

    PMID:
    15374529
    [PubMed - indexed for MEDLINE]
    16.

    Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.

    Eriksen J, Mwankusye S, Mduma S, Kitua A, Swedberg G, Tomson G, Gustafsson LL, Warsame M.

    Trans R Soc Trop Med Hyg. 2004 Jun;98(6):347-53.

    PMID:
    15099990
    [PubMed - indexed for MEDLINE]
    17.

    Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.

    Djaman JA, Mazabraud A, Basco L.

    Ann Trop Med Parasitol. 2007 Mar;101(2):103-12.

    PMID:
    17316496
    [PubMed - indexed for MEDLINE]
    19.

    Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.

    Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.

    Trop Med Int Health. 2005 Sep;10(9):901-8.

    PMID:
    16135198
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania.

    Jelinek T, Rønn AM, Lemnge MM, Curtis J, Mhina J, Duraisingh MT, Bygbjerg IC, Warhurst DC.

    Trop Med Int Health. 1998 Aug;3(8):605-9.

    PMID:
    9735930
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk